The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin β-Like 1-β-Catenin Protein Complex
Raffaella Soldi(Banner Health), Sunil Sharma(Translational Genomics Research Institute), Mohan R. Kaadige(Translational Genomics Research Institute), Kevin Drenner(Translational Genomics Research Institute), Tithi Ghosh(Translational Genomics Research Institute), Trason Thode(Translational Genomics Research Institute), Serina Ng(Translational Genomics Research Institute), Samuel Sampson(Translational Genomics Research Institute), Ryan Rodriguez del Villar(Translational Genomics Research Institute), Kapil N. Bhalla(The University of Texas MD Anderson Cancer Center), Stephen Horrigan(Translational Genomics Research Institute), Hariprasad Vankayalapati(University of Utah), Ravi Salgia(City Of Hope National Medical Center), Surinder K. Batra(Nebraska Medical Center), Alexis Weston(Translational Genomics Research Institute)
Cited by 15
Related Papers
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
|Journal for ImmunoTherapy of Cancer|2018|1.3k
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90
|Journal of Biological Chemistry|2005|749
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551
Clinical experience with the <scp>BCL</scp>2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
|American Journal of Hematology|2017|437
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
|Nature Communications|2020|383